• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胶质瘤管理实用指南]

[A practical guide for the management of gliomas].

作者信息

Stupp Roger, Pica Alessia, Mirimanoff René O, Michielin Olivier

机构信息

Centre pluridisciplinaire d'oncologie, Centre hospitalier universitaire vaudois(CHUV), 46, rue du Bugnon, CH-1011 Lausanne, Suisse.

出版信息

Bull Cancer. 2007 Sep;94(9):817-22.

PMID:17878102
Abstract

The management of gliomas in daily clinical practice is challenging. It requires a multidisciplinary and coordinated approach involving neurosurgery, radiotherapy and, finally, chemotherapy. Important progress has been made during the last years with the introduction of a combined treatment associating standard radiotherapy with concomitant chemotherapy using temozolomide, a novel alkylating agent. For the first time in many years a new treatment strategy translated into a significant prolongation of survival. In parallel, molecular markers (e.g. loss of heterozygosity on chromosomes 1p and 19q or methylation of the methyl-guanine methyl transferase [MGMT] gene promoter) allowed for identification of distinct subtypes of glioma or prediction of treatment response. In this "Practical Guide", we describe the daily practice and aim at answering some common questions in the management of patients suffering from glioblastoma, astrocytoma, oligodendroglioma and low grade glioma. The therapeutic options presented here are based on evidences from the literature. In the absence of documented evidence, the empirical choices from our local practice are explained and justified.

摘要

在日常临床实践中,胶质瘤的管理具有挑战性。它需要一种多学科协调的方法,涉及神经外科、放射治疗,最后是化疗。在过去几年中,随着将标准放疗与使用新型烷化剂替莫唑胺的同步化疗相结合的联合治疗方法的引入,取得了重要进展。多年来,一种新的治疗策略首次转化为显著延长生存期。与此同时,分子标志物(例如1号染色体和19号染色体上的杂合性缺失或甲基鸟嘌呤甲基转移酶[MGMT]基因启动子的甲基化)有助于识别不同类型的胶质瘤或预测治疗反应。在本“实用指南”中,我们描述了日常实践,并旨在回答胶质母细胞瘤、星形细胞瘤、少突胶质细胞瘤和低级别胶质瘤患者管理中的一些常见问题。这里介绍的治疗选择基于文献证据。在没有文献证据的情况下,我们会解释并说明本地实践中的经验性选择及其依据。

相似文献

1
[A practical guide for the management of gliomas].[胶质瘤管理实用指南]
Bull Cancer. 2007 Sep;94(9):817-22.
2
[Therapeutic strategies for the management of gliomas].[胶质瘤治疗策略]
Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):523-30. doi: 10.1016/j.neurol.2008.03.012. Epub 2008 May 13.
3
Diagnostic and prognostic molecular markers in common adult gliomas.常见成人脑胶质瘤的诊断和预后分子标志物。
Expert Rev Mol Diagn. 2010 Jul;10(5):637-49. doi: 10.1586/erm.10.44.
4
The changing management of low-grade astrocytomas and oligodendrogliomas.低级别星形细胞瘤和少突胶质细胞瘤管理方式的变化
Hematol Oncol Clin North Am. 2006 Dec;20(6):1249-66. doi: 10.1016/j.hoc.2006.09.003.
5
The role of cytotoxic drugs in the treatment of central nervous system gliomas.细胞毒药物在中枢神经系统神经胶质瘤治疗中的作用。
Acta Neurol Belg. 2010 Mar;110(1):1-14.
6
Molecular genetic markers as predictors of response to chemotherapy in gliomas.分子遗传标志物作为胶质瘤化疗反应的预测指标。
Curr Opin Oncol. 2007 Nov;19(6):606-11. doi: 10.1097/CCO.0b013e3282f075f3.
7
Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.整合分子分析提示低级别胶质瘤的三分类模型:概念验证研究。
Genomics. 2010 Jan;95(1):16-24. doi: 10.1016/j.ygeno.2009.09.007. Epub 2009 Oct 14.
8
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
9
Changing paradigms--an update on the multidisciplinary management of malignant glioma.范式转变——恶性胶质瘤多学科管理的最新进展
Oncologist. 2006 Feb;11(2):165-80. doi: 10.1634/theoncologist.11-2-165.
10
Multidisciplinary management of adult low grade gliomas.成人低级别胶质瘤的多学科管理
Chirurgia (Bucur). 2014 Sep-Oct;109(5):590-9.

引用本文的文献

1
Cell-based immunotherapy against gliomas: from bench to bedside.基于细胞的脑胶质瘤免疫治疗:从基础到临床。
Mol Ther. 2013 Jul;21(7):1297-305. doi: 10.1038/mt.2013.80. Epub 2013 May 7.
2
Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a review.磁敏感加权成像在颅内胶质瘤检测和分级中的临床应用:综述。
Cancer Imaging. 2013 Apr 24;13(2):186-95. doi: 10.1102/1470-7330.2013.0020.
3
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
复发性胶质母细胞瘤的低分割立体定向再照射:高剂量放疗后的一种有益治疗选择?
Strahlenther Onkol. 2009 Apr;185(4):235-40. doi: 10.1007/s00066-009-1753-x. Epub 2009 Apr 16.